Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Non-Current Assets (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Non-Current Assets for 2 consecutive years, with $27.4 million as the latest value for Q3 2023.

  • On a quarterly basis, Non-Current Assets fell 24.5% to $27.4 million in Q3 2023 year-over-year; TTM through Sep 2023 was $149.5 million, a N/A change, with the full-year FY2022 number at $46.5 million, changed N/A from a year prior.
  • Non-Current Assets was $27.4 million for Q3 2023 at LENZ Therapeutics, down from $35.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $46.5 million in Q4 2022 to a low of $27.1 million in Q2 2022.